Skip to main content
Top
Published in: International Urogynecology Journal 7/2020

01-07-2020 | Radiotherapy | Original Article

Surgical outcomes of vesicovaginal fistulae in patients with previous pelvic radiotherapy

Authors: Bogdan Toia, Mahreen Pakzad, Rizwan Hamid, Tamsin Greenwell, Jeremy Ockrim

Published in: International Urogynecology Journal | Issue 7/2020

Login to get access

Abstract

Introduction and hypothesis

Vesicovaginal fistulae (VVF) repair success rates for simple surgical fistulae are high, but constitute a significantly greater challenge when occurring in a radiotherapy field. We aim to evaluate the causes, assessment, closure rates and functional outcomes of VVF surgery in patients with previous radiotherapy.

Methods

Data on all VVF repairs were collected prospectively. A retrospective review of outcomes in those with VVF performed between 2009 and 2018 was carried out. Details including time from radiotherapy, pre-operative assessments, approach to surgery and functional outcome were analysed.

Results

Twenty women with VVFs were identified. The mean age was 59 (range 25–88) years. Primary malignancy was cervical in 16 women, with the remaining 4 women having ovarian, urethral, endometrial and rectal cancer respectively. All women had external beam radiotherapy with 6 (30%) undergoing boosted brachytherapy. Mean interval between radiotherapy and fistula repair was 19 (range 0–40) years. Fistulae arose spontaneously in 14 patients, whereas 6 occurred following a further surgical intervention.Closure was attempted vaginally in 7 women and abdominally in 1, whereas 12 had a primary diversion owing to significant bladder contracture and ureteric involvement. The closure rate in those attempted was 62.5%, 40% in those with spontaneous fistulae compared with 100% for post-surgical fistulae, but only 20% for the total cohort.

Conclusions

Closure of VVF is a significant challenge, with an initial success rate of 20% and an overall success rate of only 25%. Seventy percent required primary or secondary urinary diversion. Vaginal surgery was utilised in the majority to try to avoid a hostile pelvis, but the surgical approach should be tailored to individual circumstances.
Literature
2.
go back to reference Cromwell D, Hilton P. Retrospective cohort study on patterns of care and outcomes of surgical treatment for lower urinary-genital tract fistula among English National Health Service hospitals between 2000 and 2009. BJU Int. 2013;111(Pt 4B):E257–62.CrossRef Cromwell D, Hilton P. Retrospective cohort study on patterns of care and outcomes of surgical treatment for lower urinary-genital tract fistula among English National Health Service hospitals between 2000 and 2009. BJU Int. 2013;111(Pt 4B):E257–62.CrossRef
3.
go back to reference Bodner-Adler B, Hanzal E, Pablik E, Koelbl H, Bodner K. Management of vesicovaginal fistulas (VVFs) in women following benign gynaecologic surgery: a systematic review and meta-analysis. PLoS One. 2017;12(2):1–21.CrossRef Bodner-Adler B, Hanzal E, Pablik E, Koelbl H, Bodner K. Management of vesicovaginal fistulas (VVFs) in women following benign gynaecologic surgery: a systematic review and meta-analysis. PLoS One. 2017;12(2):1–21.CrossRef
4.
go back to reference Joye I, Haustermans K. Early and late toxicity of radiotherapy for rectal cancer. Recent Results Cancer Res. 2014;203:189–201.CrossRef Joye I, Haustermans K. Early and late toxicity of radiotherapy for rectal cancer. Recent Results Cancer Res. 2014;203:189–201.CrossRef
5.
go back to reference Marks LB, Carroll PR, Dugan TC, Anscher MS. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol. 1995;31(5):1257–80.CrossRef Marks LB, Carroll PR, Dugan TC, Anscher MS. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol. 1995;31(5):1257–80.CrossRef
6.
go back to reference Mondet F, Chartier-Kastler EJ, Conort P, Bitker MO, Chatelain C, Richard F. Anatomic and functional results of transperitoneal-transvesical vesicovaginal fistula repair. Urology. 2001;58(6):882–6.CrossRef Mondet F, Chartier-Kastler EJ, Conort P, Bitker MO, Chatelain C, Richard F. Anatomic and functional results of transperitoneal-transvesical vesicovaginal fistula repair. Urology. 2001;58(6):882–6.CrossRef
7.
go back to reference Langkilde NC, Pless TK, Lundbeck F, Nerstrøm B. Surgical repair of vesicovaginal fistulae—a ten-year retrospective study. Scand J Urol Nephrol. 1999;33(2):100–3.CrossRef Langkilde NC, Pless TK, Lundbeck F, Nerstrøm B. Surgical repair of vesicovaginal fistulae—a ten-year retrospective study. Scand J Urol Nephrol. 1999;33(2):100–3.CrossRef
8.
go back to reference Hilton P. Urogenital fistula in the UK: a personal case series managed over 25 years. BJU Int. 2012;110(1):102–10.CrossRef Hilton P. Urogenital fistula in the UK: a personal case series managed over 25 years. BJU Int. 2012;110(1):102–10.CrossRef
9.
go back to reference Pushkar DY, Dyakov VV, Kasyan GR. Management of radiation-induced vesicovaginal fistula. Eur Urol. 2009;55(1):131–8.CrossRef Pushkar DY, Dyakov VV, Kasyan GR. Management of radiation-induced vesicovaginal fistula. Eur Urol. 2009;55(1):131–8.CrossRef
10.
go back to reference Toia B, Seth J, Ecclestone H, Pakzad M, Hamid R, Greenwell T, et al. Outcomes of reconstructive urinary tract surgery after pelvic radiotherapy. Scand J Urol. 2019;53(2–3):156–60.CrossRef Toia B, Seth J, Ecclestone H, Pakzad M, Hamid R, Greenwell T, et al. Outcomes of reconstructive urinary tract surgery after pelvic radiotherapy. Scand J Urol. 2019;53(2–3):156–60.CrossRef
11.
go back to reference Liberman D, Mehus B, Elliott SP. Urinary adverse effects of pelvic radiotherapy. Transl Androl Urol. 2014;3(2):186–95.PubMedPubMedCentral Liberman D, Mehus B, Elliott SP. Urinary adverse effects of pelvic radiotherapy. Transl Androl Urol. 2014;3(2):186–95.PubMedPubMedCentral
12.
go back to reference Turesson I. Individual variation and dose dependency in the progression rate of skin telangiectasia. Int J Radiat Oncol Biol Phys. 1990;19(6):1569–74.CrossRef Turesson I. Individual variation and dose dependency in the progression rate of skin telangiectasia. Int J Radiat Oncol Biol Phys. 1990;19(6):1569–74.CrossRef
13.
go back to reference Perez CA, Grigsby PW, Lockett MA, Chao KS, Williamson J. Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys. 1999;44(4):855–66.CrossRef Perez CA, Grigsby PW, Lockett MA, Chao KS, Williamson J. Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys. 1999;44(4):855–66.CrossRef
14.
go back to reference Abrams P, Cardozo L, Khoury S, Wein AJ, International Continence Society. Incontinence: 5th International Consultation on Incontinence, Paris, February 2012. ICUD-EAU; 2013. Abrams P, Cardozo L, Khoury S, Wein AJ, International Continence Society. Incontinence: 5th International Consultation on Incontinence, Paris, February 2012. ICUD-EAU; 2013.
15.
go back to reference Miller EA, Webster GD. Current management of vesicovaginal fistulae. Curr Opin Urol. 2001;11(4):417–21.CrossRef Miller EA, Webster GD. Current management of vesicovaginal fistulae. Curr Opin Urol. 2001;11(4):417–21.CrossRef
16.
go back to reference Gousse AE, Evans DH, Madjar S, Politano VA, Bejany DE, Lynne CM. Interposition flaps in transabdominal vesicovaginal fistula repairs: are they really necessary? Urology. 2001;57(4):670–4.CrossRef Gousse AE, Evans DH, Madjar S, Politano VA, Bejany DE, Lynne CM. Interposition flaps in transabdominal vesicovaginal fistula repairs: are they really necessary? Urology. 2001;57(4):670–4.CrossRef
Metadata
Title
Surgical outcomes of vesicovaginal fistulae in patients with previous pelvic radiotherapy
Authors
Bogdan Toia
Mahreen Pakzad
Rizwan Hamid
Tamsin Greenwell
Jeremy Ockrim
Publication date
01-07-2020
Publisher
Springer International Publishing
Keyword
Radiotherapy
Published in
International Urogynecology Journal / Issue 7/2020
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-019-04217-z

Other articles of this Issue 7/2020

International Urogynecology Journal 7/2020 Go to the issue